NAD+ and Aging: What It Is, Why It Declines, and What You Can Do

Co-authored by Vittorio Sebastiano, PhD. Professor of Biological Chemistry, UC Irvine, and Adjunct Professor at Stanford University School of Medicine. Pioneer of Epigenetic Reprogramming of Aging (ERA), with 50+ publications in Nature, Science, and Cell.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that powers cellular energy metabolism and supports hundreds of enzymatic reactions essential for life. NAD+ levels decline significantly with age, particularly after age 40, impairing mitochondrial function and cellular repair processes. Research suggests restoring NAD+ through lifestyle and targeted supplementation may support healthy energy metabolism and cellular vitality.

What Is NAD+ and Why Does It Matter?

NAD+ is a coenzyme that transfers electrons during energy production and activates sirtuins, which regulate cellular maintenance and stress resistance. It exists in two forms, NAD+ (oxidized) and NADH (reduced), and operates in every cell of your body. NAD+ levels are so fundamental to health that they influence aging trajectories across species.

NAD+ stands for nicotinamide adenine dinucleotide. The name describes its structure: adenine (a nucleobase), ribose (a sugar), and nicotinamide (a form of vitamin B3), all connected into a single molecule. But what matters far more than the chemistry is what NAD+ does.

Think of NAD+ as an electron shuttle. During cellular respiration, the process by which your cells convert glucose and fat into usable energy (ATP), NAD+ accepts electrons and becomes NADH. NADH then carries those electrons to your mitochondria, where they power the electron transport chain. Without this electron relay system, energy production stalls. Your cells can no longer fuel their operations.

But NAD+ does something else equally important: it powers a family of enzymes called sirtuins. Sirtuins are cellular "caretakers" that regulate DNA repair, mitochondrial biogenesis, autophagy (cellular cleanup), and inflammatory responses. When NAD+ levels are high, sirtuins are active. When NAD+ levels drop, sirtuin activity declines, and cellular maintenance falters.

This dual role, energy production and cellular repair, is why NAD+ has become one of the most studied molecules in longevity science.

Why NAD+ Declines with Age

NAD+ levels decline primarily due to increased consumption by NAD+-using enzymes (PARPs, CD38, sirtuins), declining NAD+ synthesis capacity, and reduced expression of NAMPT, the rate-limiting enzyme in NAD+ salvage. This decline accelerates after age 40 and contributes to mitochondrial dysfunction, reduced DNA repair, and impaired stress resistance.

The Decline Is Real, and Measurable

NAD+ blood levels decline significantly with age. Across recent clinical trials, placebo groups (untreated controls) averaged whole-blood NAD+ concentrations of approximately 23.8 μM (micromolar). That decline matters: it represents a meaningful reduction in the molecular fuel supporting your cells' most essential functions. Studies show this decline occurs broadly, in muscle, liver, brain, and immune tissues, though the rate and severity vary by tissue type and individual.

The timeline matters. NAD+ begins declining in your 30s and 40s, accelerates through your 50s and 60s, and continues into later decades. By age 60, whole-blood NAD+ can be roughly half of what it was in young adulthood, though individual variation is significant.

Expert Perspective: Vittorio Sebastiano, PhD

Vittorio Sebastiano, PhD, Professor, Biological Chemistry, UC Irvine

NAD+ is often discussed as an energy molecule, but its role in epigenetic maintenance is equally important. Sirtuins, the enzymes that depend on NAD+, are critical regulators of chromatin structure and gene expression patterns. When NAD+ declines with age, sirtuin activity drops, and the epigenetic environment begins to degrade. In our reprogramming work, we have observed that restoring epigenetic integrity can reverse multiple hallmarks of aging simultaneously. Supporting NAD+ levels is one way to help maintain that integrity before more extensive interventions become necessary.

Why the Decline Happens

Several mechanisms drive NAD+ decline:

1. Increased NAD+ Consumption

NAD+ isn't just sitting in your cells, it's being actively used. Enzymes called PARPs (poly-ADP-ribose polymerases) consume NAD+ during DNA repair after oxidative damage. CD38, an immune enzyme, drains NAD+ pools during immune activation. Sirtuins themselves consume NAD+ to perform their maintenance functions. As oxidative stress and immune activation increase with age, NAD+ consumption accelerates. Your body burns through its NAD+ faster.

2. Declining NAD+ Synthesis

Your body synthesizes NAD+ through two main pathways:

• The de novo pathway: Starts from tryptophan (an amino acid) and is slow, producing only a small amount of NAD+ per day. This pathway becomes less efficient with age.
• The salvage pathway: Recycles nicotinamide (a NAD+ breakdown product) back into NAD+. This pathway is controlled by an enzyme called NAMPT (nicotinamide phosphoribosyltransferase), which is the rate-limiting step. NAMPT expression declines with age, reducing recycling capacity.

As both pathways slow, NAD+ synthesis can no longer keep pace with consumption. The pool shrinks.

3. Increased Cellular Stress

Oxidative stress and inflammation, hallmarks of aging, trigger increased NAD+ consumption. This creates a vicious cycle: aging tissues become more stressed, stress increases NAD+ consumption, NAD+ depletion impairs stress defenses, and cellular stress accelerates further.

The result is a coordinated decline in energy production, DNA repair, mitochondrial maintenance, and stress resistance. This is not a single disease but a systems-level dysfunction that manifests as fatigue, cognitive sluggishness, metabolic inflexibility, and accelerated biological aging.

What NAD+ Does: The Cellular Power System

NAD+ fuels energy production in mitochondria, powers sirtuins for cellular repair and stress resistance, and regulates circadian rhythm and metabolic flexibility. When NAD+ is depleted, all of these processes falter, contributing to fatigue, metabolic dysfunction, and accelerated aging.

Energy Metabolism: The Primary Role

NAD+ is essential to the citric acid cycle (Krebs cycle) and electron transport chain, the machinery that converts food into ATP (adenosine triphosphate), the energy currency of cells. Here's the simplified picture:

1. Glucose or fat is broken down
2. NAD+ accepts electrons (becomes NADH)
3. NADH shuttles electrons to the electron transport chain in your mitochondria
4. This electron movement pumps protons, creating a gradient
5. ATP synthase uses this gradient to manufacture ATP
6. Your cells use ATP to do everything, contract muscle, fire neurons, synthesize proteins, regulate temperature

When NAD+ is depleted, this process becomes inefficient. Your cells produce less ATP per unit of fuel. This is why NAD+ depletion correlates with fatigue and reduced physical capacity in aging.

Sirtuin-Mediated Cellular Maintenance

Sirtuins are NAD+-dependent enzymes that sense cellular energy status and trigger maintenance and repair:

• SIRT1 regulates PGC-1α, the master regulator of mitochondrial biogenesis (building new mitochondria). It also activates FOXO, which enhances stress resistance and DNA repair. When NAD+ is low, SIRT1 activity drops, and mitochondrial renewal slows.
• SIRT3 operates inside mitochondria, regulating oxidative stress defenses. When NAD+ is depleted, mitochondrial antioxidant capacity falls, and oxidative damage accelerates.
• SIRT6 regulates DNA repair and reduces inflammation. Its decline with NAD+ depletion contributes to genomic instability and chronic inflammation.

When NAD+ is restored, sirtuins become more active, triggering a cascade of cellular maintenance responses. This is mechanistically why NAD+ elevation has been associated with improved metabolic health and stress resistance in animal studies.

Metabolic Flexibility and Circadian Health

NAD+ also regulates the circadian clock and metabolic flexibility, your body's ability to switch between burning carbohydrates and fat for fuel. NAD+-dependent sirtuins (particularly SIRT1) synchronize circadian rhythm, which coordinates sleep-wake cycles, hormone secretion, and metabolism. NAD+ depletion is associated with circadian desynchronization, which impairs sleep quality and metabolic control.

What the Research Shows: NAD+ Elevation and Clinical Outcomes

Research demonstrates that NMN and NR precursors significantly elevate whole-blood NAD+ in humans at doses of 250 to 600 mg daily. Human clinical outcomes are more modest but promising: studies show benefits for insulin sensitivity, sleep quality, and physical performance, particularly in older and metabolically compromised populations. The evidence is best described as moderate, promising but preliminary.

NAD+ Elevation Is Established

Multiple human trials have confirmed that oral precursors (NMN and NR) raise blood NAD+ levels:

• Dose-response: NAD+ elevation is dose-dependent across the studied range, with higher doses producing larger increases over baseline.
• Dose validation: 350mg of NMN per day produced significant NAD+ elevation in healthy men over 40 (n=15, 4-week randomized study, February 2025). In that study, a liposomal NMN form raised NAD+ more than standard NMN.

This elevation is dose-dependent and durable over weeks. The principle is established: supplementing with NAD+ precursors does restore blood NAD+ levels.

Physical Function and Sleep: The Strongest Human Data

Morifuji et al. (2024); GeroScience, DOI: 10.1007/s11357-024-01204-1

This randomized controlled trial tested 250mg NMN daily for 12 weeks in older adults (65 to 75 years old). Results:

• Walking speed improved: 4-meter walking time significantly shorter in the NMN group, indicating enhanced lower-body strength and physical function
• Sleep quality significantly improved: Pittsburgh Sleep Quality Index (PSQI) scores improved, with significant reductions in daytime dysfunction and global sleep quality measures
• NAD+ blood levels elevated: confirmed NAD+ elevation vs. placebo

Kim et al. (2022); PMC 8877443

A separate trial of 250mg NMN for 12 weeks in older Japanese adults showed:

• Significant reduction in drowsiness and fatigue
• Improved lower-limb function and reduced drowsiness, with the strongest effects when NMN was taken in the afternoon or evening rather than the morning
• Corroborated the Morifuji findings

Yi et al. (2023); GeroScience, DOI: 10.1007/s11357-022-00705-1

A dose-ranging trial randomized 80 healthy adults aged 40 to 65 to placebo or 300, 600, or 900mg NMN daily for 60 days. It adds what the single-dose trials above cannot:

• Dose-response: blood NAD+ rose significantly in every NMN group versus placebo, with the largest increases at 600 and 900mg. Six-minute walk distance and self-reported health (SF-36) improved at 600 and 900mg, but not at 300mg.
• A blood-biomarker estimate of biological age (Aging.AI) rose over the two months in the placebo group while holding steady in the NMN groups. This is a secondary endpoint from a single trial using a machine-learning estimate, not an epigenetic clock, so read it as a signal, not proof.

These trials represent the strongest human evidence for NMN's functional benefits. Most occurred in older or middle-aged populations; effects in younger, healthy adults are less clear.

Insulin Sensitivity and Metabolic Health: Population-Specific Benefits

Yoshino et al. (2021); Science, DOI: 10.1126/science.abe9985

This study tested 250mg NMN in prediabetic women and found:

• About 25% improvement in insulin sensitivity in muscle tissue
• Upregulated PDGF receptor β and muscle remodeling genes, molecular markers of improved metabolic capacity
• Population-specific: benefits were most pronounced in metabolically compromised (prediabetic) women

Meta-Analysis (2024); Critical Reviews in Food Science and Nutrition, PMID: 39116016

A systematic review and meta-analysis of NMN randomized trials in adults (12 studies, 513 participants, doses 250 to 2000 mg/day) found:

• NAD+ elevation: confirmed across studies
• Metabolic markers: fasting glucose, insulin, HbA1c, HOMA-IR, and lipid profiles were not significantly different between NMN and placebo overall

The headline is consistent with the rest of the evidence: NMN reliably raises NAD+, but in mostly healthy adults it did not move standard glucose and lipid markers.

Critical assessment: NMN appears to support insulin sensitivity primarily in individuals with metabolic concerns (prediabetes, metabolic syndrome). Effects in healthy, younger populations are less clear and may require higher doses or longer intervention windows.

What the Research Actually Shows

We classify NMN at a moderate evidence tier. This means:

• NAD+ elevation is established at studied doses
• Multiple human trials show safety and tolerability
• Specific outcomes (sleep, insulin sensitivity) show promise in particular populations
• Large-scale, long-term lifespan extension in humans is unproven
• Clinical efficacy is less well-established than the mechanistic evidence might suggest
• Most clinically relevant outcomes (glucose, lipid profiles) were not significantly different from placebo in the meta-analysis across all populations

This is not a weakness of NMN, it's an honest reading of early-stage human evidence. Many promising compounds eventually fail in larger trials. Some succeed. The data here is encouraging but not conclusive.

NMN vs. NR: Which NAD+ Precursor?

Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) significantly raise NAD+. The difference is proximity: inside the cell, NMN is the direct precursor that the enzyme NMNAT converts to NAD+ in a single step, while NR has to be converted to NMN first. That one-step route to NAD+ is the main reason TimeWarp uses NMN. NR has its own human evidence, including a crossover pilot in which 1000mg/day raised NAD+ about 60% and lowered systolic pressure by roughly 10 points in people with elevated blood pressure (Martens et al., Nature Communications 2018). How the two compare head to head is covered below.

The NAD+ Salvage Pathway

Both NMN and NR are precursors in the NAD+ salvage pathway, the recycling system that turns nicotinamide back into NAD+:

Nicotinamide -> (NAMPT enzyme) -> NMN -> (NMNAT enzyme) -> NAD+
                                   ^
                       NR -> (NRK enzyme)

The pathway shows a key difference: NR must be converted to NMN before becoming NAD+. This makes NMN one enzymatic step closer to the end product.

Why Not Just Take NAD+ Directly?

If NAD+ is the molecule that matters, the obvious question is why supplements sell precursors instead of NAD+ itself. The answer is that oral NAD+ does not arrive intact.

NAD+ is a large, charged molecule. It cannot cross the intestinal wall in one piece. Enzymes in the gut and bloodstream, including CD73 and CD38, break it down into nicotinamide and nicotinamide riboside before it reaches circulation. Whatever effect an oral NAD+ product has comes from those breakdown pieces entering the salvage pathway above, not from the NAD+ on the label. You are buying an expensive delivery vehicle for cheaper molecules.

Liposomal delivery does not solve this. Liposomal encapsulation is designed to improve absorption of intact molecules across the gut wall, and for some compounds it works well. It does not prevent enzymatic cleavage in the gut lumen and bloodstream, and it does not change the fact that NAD+ has to be assembled inside the cell regardless of how it arrives. Better absorption of a molecule that gets disassembled on the way is still disassembly. This is specific to NAD+ itself. Encapsulating a precursor that survives absorption is a different proposition, and one study did find a liposomal NMN form outperformed standard NMN.

This matters because of which fragment you end up with. In the Christen 2025 trial described below, NR and NMN both roughly doubled whole-blood NAD+ over 14 days. Nicotinamide, dosed alongside them in the same study, produced no sustained elevation at all. Ending up at nicotinamide is the weakest outcome in the salvage pathway, and it is where oral NAD+ largely lands.

NMN and NR are stable, absorbable, and enter the pathway at a useful point. That is the entire reason precursors exist as a category.

Cellular Uptake: The Long-Debated Question

For years, researchers debated whether NMN could directly enter cells, or whether it had to be converted to NR first in the bloodstream. The reason: NMN is large and charged (due to its phosphate group), and shouldn't be able to cross cell membranes via passive diffusion.

Grozio et al. (2019), Nature Metabolism

This study identified Slc12a8, a protein that functions as a dedicated NMN transporter, allowing direct NMN uptake into cells without prior conversion to NR. They used isotopic tracing to demonstrate direct uptake.

Schmidt and Brenner (2019), Nature Metabolism

These researchers published a critical response contesting the analytical methods and interpretation, arguing the evidence wasn't as strong as claimed.

The current state: Multiple subsequent studies have supported the existence of the Slc12a8 transporter, but it remains an active area of debate. The transporter appears to exist, but its functional significance and tissue distribution are still being characterized. Recent research has identified this potential dedicated NMN transporter, which would allow direct NMN uptake into cells, and multiple studies now support the mechanism.

Head-to-Head Comparison

Two recent trials compared the precursors head to head in humans, and on blood NAD+ they come out close.

Christen et al. (2025); Nature Metabolism. A randomized, placebo-controlled trial in about 65 healthy adults gave 1000mg/day NR, 1000mg/day NMN, nicotinamide, or placebo for 14 days. NR and NMN both roughly doubled whole-blood NAD+, with no meaningful difference between them (a rise of about 49 µM for NR and 43 µM for NMN). Nicotinamide had no sustained effect.

Berven et al. (2026); iScience. A small crossover pharmacokinetic study in 6 adults compared 1200mg/day of each over 8 days. Here NR raised whole-blood NAD+ more than NMN (about 161% versus 69% from baseline), though the sample was tiny and the dose high. Part of that gap is dosing chemistry: a gram of NR chloride carries about 15% more molecules than a gram of NMN.

Mechanistic position: Inside the cell, NMN is the direct precursor to NAD+, converted in one step by NMNAT, while NR has to be converted to NMN first. That one-step proximity is a real reason to favor NMN. Two nuances keep the picture honest: getting NMN into cells may involve conversion to NR at the cell surface, and the head-to-head trials above show the two raise blood NAD+ comparably. So TimeWarp uses NMN for its direct, one-step route to NAD+ and for the deeper bench of aging-focused human trials that used it (the walk-speed, insulin, and sleep studies above), while we avoid claiming it raises NAD+ more than NR, which the data does not show.

NMN Broader Benefits: Insulin Sensitivity and Sleep

Beyond NAD+ elevation, NMN has shown specific benefits for insulin sensitivity in prediabetic populations and sleep quality in older adults, particularly when dosed in the evening. These effects are supported by randomized controlled trials but are population-specific and should not be assumed to transfer to all users.

Insulin Sensitivity: Yoshino 2021

We covered this above, but the point merits emphasis: NMN's best-supported clinical endpoint beyond NAD+ elevation is improved insulin sensitivity in prediabetic women. This reflects a real biological effect. However, this benefit appeared primarily in a metabolically compromised population. Extrapolating to healthy 30-year-olds would be inappropriate.

Safe framing: "NMN has shown promising effects on insulin sensitivity in early clinical research, particularly in individuals with metabolic concerns. Effects in healthy populations are less well-established."

Sleep Quality: Morifuji 2024, Kim 2022

Two randomized controlled trials reported significant improvements in sleep quality with 250mg NMN taken in the evening in older adults (ages 65 to 75). This is not a small effect. Sleep quality (measured by the Pittsburgh Sleep Quality Index) improved by statistically and clinically significant margins. An ongoing multicenter RCT at Mayo Clinic is testing NMN for chronic insomnia, with results pending.

Why evening dosing matters: NAD+ participates in circadian rhythm regulation. The sirtuin-NAD+ axis coordinates the circadian clock, which orchestrates sleep-wake cycles, hormone secretion, and metabolic processes. Dosing in the evening may align NAD+ elevation with circadian timing, enhancing sleep benefits.

Safe framing: "Two randomized controlled trials have reported improvements in sleep quality with 250mg NMN taken in the evening in older adults. Evidence in younger populations is not yet available."

Dosing: What the Studies Show and What TimeWarp Includes

Clinical trials evaluating NMN have used doses ranging from 250mg to 600mg daily. TimeWarp includes 350mg per day, placing it within the studied range. This dose has demonstrated NAD+ elevation in human trials.

The Clinical Dose Range

Studies evaluating NMN have employed:

• 250mg/day: sleep and physical function benefits (Morifuji 2024, Kim 2022)
• 350mg/day: demonstrated NAD+ elevation (February 2025 study)
• 500mg/day: dose-response studies showing significant NAD+ elevation
• 600mg/day: physical performance benefits in some studies
• 1000mg/day: high-dose studies showing substantial NAD+ elevation but no added clinical benefit over lower doses

TimeWarp's 350mg Dose

TimeWarp Protocol 01 includes 350mg of NMN in the daily Energize dose. This dose:

• Is within the clinically studied range (250 to 600mg)
• Has demonstrated NAD+ elevation in human trials, including a 350mg/day study in healthy men over 40 (February 2025)
• Falls within the dose range shown to elevate NAD+ levels in human trials
• Sits near the 250mg dose used in the sleep and physical-function studies (Morifuji, Kim)

Honest positioning: "Studies use 250 to 600mg; TimeWarp includes 350mg. The optimal dose for different populations is still being determined. This dose has demonstrated NAD+ elevation and preliminary clinical benefits in older adults; effects in younger, healthy populations require further study."

We do not claim that 350mg is "optimal" or "most effective," that would exceed the current evidence base. We present it as a dose that has demonstrated both NAD+ elevation and preliminary clinical benefits.

How the Formula Supports NAD+ as a System

NMN is the starting point, not the whole story. NAD+ is built, consumed, and recycled constantly, so Protocol 01 is designed to support the full cycle rather than a single step. The pairing is intentional, with the relevant ingredients grouped in the Energize formula alongside NMN. The evidence below is largely mechanistic and preclinical (cell and animal studies), not human outcome trials, so this describes design intent rather than promised effects.

• Build it: NMN.
  
  
  The immediate NAD+ precursor in the salvage pathway, at 350mg, within the clinically studied range.
• Preserve it: apigenin. 
  
  CD38 is one of the main enzymes that degrade NAD+, and its activity rises with age, which makes it a major driver of age-related NAD+ decline. Apigenin is one of the most potent natural CD38 inhibitors identified, so it is intended to reduce how quickly the NAD+ you build is consumed. A 2024 review in Frontiers in Nutrition notes that NMN and NR strategies could be improved by combining them with CD38 inhibitors, which is the logic behind pairing apigenin with NMN. In cell and animal studies, apigenin has been shown to inhibit CD38 and raise NAD+ levels (for example, in diabetic kidney models in Aging, 2020). Human outcome data is not yet available.
  
• Support the methylation it draws on: methylfolate, methyl-B12, and B6.
  
  
  When you load NAD+ precursors, excess nicotinamide is cleared by methylation through the NNMT enzyme, which uses methyl groups. The formula's methyl donors are intended to support that methylation load so precursor intake does not draw down methylation capacity elsewhere. Most NAD+ products leave this to the customer, typically by suggesting a separate TMG purchase. The cofactors are built into the same formula here.
  
  
• Activate what NAD+ powers: pterostilbene.
  
  
  NAD+ fuels the sirtuins. Pterostilbene is a sirtuin-supporting polyphenol, included so that raising NAD+ pairs with activation of the enzymes NAD+ drives. Evidence here is mechanistic and early-clinical.
  
• Stimulate synthesis: dihydroberberine.
  
  
  Dihydroberberine activates AMPK, the same energy-sensing pathway through which exercise and caloric restriction raise NAD+ synthesis. This is a mechanistic rationale, not a proven NAD+ outcome in humans.

Taken together, the design intent is a NAD+ system: build it, slow its loss, support its methylation load, activate what it powers, and stimulate its synthesis. We describe this as engineering rationale, not as a promise that any single number on your own biological-age test will change.

Lifestyle Interventions: Natural NAD+ Support

Exercise, caloric restriction, intermittent fasting, time-restricted eating, and specific dietary components (polyphenols, nicotinamide) naturally influence NAD+ metabolism. These should be the foundation. Supplementation complements rather than replaces lifestyle strategies.

Exercise: The Strongest NAD+ Stimulus

Endurance exercise (aerobic activity) activates AMPK, which triggers NAD+-dependent sirtuins and promotes mitochondrial biogenesis. This is one of the reasons exercise has such profound longevity-promoting effects. Both acute exercise and chronic exercise training improve NAD+ dynamics and sirtuin-mediated cellular maintenance.

Mechanism: Exercise depletes ATP, raising the AMP:ATP ratio, which activates AMPK. AMPK then promotes NAD+ synthesis and mitochondrial renewal. This is a genuine, evolutionarily conserved pathway connecting movement to longevity.

Caloric Restriction and Fasting

Caloric restriction and intermittent fasting activate AMPK and sirtuins, enhancing NAD+ signaling. Time-restricted eating (eating within a confined window, like 8 hours per day) also improves metabolic flexibility and NAD+-sirtuin axis function.

These interventions appear to work partly through enhancing NAD+ signaling, not just through reducing overall calories.

Dietary Polyphenols

Certain plant compounds, resveratrol, quercetin, apigenin, and others, may influence NAD+ metabolism or activate sirtuins directly. While their effects are more modest than NMN supplementation, polyphenol-rich foods (berries, green tea, red wine, dark chocolate) are associated with improved metabolic health and may complement NAD+ support.

Nicotinamide and Niacin

Dietary nicotinamide (a form of vitamin B3) feeds directly into the NAD+ salvage pathway. While most people get adequate dietary niacin, increasing nicotinamide-rich foods (chicken, turkey, mushrooms, tuna) supports NAD+ pools.

Sleep and Stress Management

NAD+ is involved in circadian regulation and stress resistance. Poor sleep and chronic stress both deplete NAD+ and impair sirtuin function. Good sleep hygiene and stress management are foundational to NAD+ health.

Practical takeaway: Supplementing with NMN while maintaining a sedentary lifestyle is like adding high-octane fuel to a poorly maintained engine. The foundation must be exercise, reasonable caloric intake, sleep, and stress management. Supplementation enhances these efforts.

Potential Side Effects and Safety Considerations

Clinical trials have reported oral NMN to be safe and well tolerated with no serious adverse reactions, including up to 1250mg/day for 4 weeks (Fukamizu et al., 2022; Scientific Reports, PMID: 36002548) and up to 900mg/day for 60 days (Yi et al., 2023). Long-term human safety data (5+ years) does not yet exist. Individuals should consult their healthcare provider before beginning NMN supplementation, particularly if taking medications or managing chronic health conditions.

Reported Side Effects (Short-Term)

Across 7 or more human trials (2023 to 2024), oral NMN at 250 to 1250mg/day for 4 to 10 weeks produced no serious adverse events and was generally well tolerated. Minor, transient symptoms occasionally reported included:

• Mild gastrointestinal discomfort
• Transient nausea
• Headache (rare)

These occurred at rates similar to placebo in most studies, suggesting they are not causally attributable to NMN.

Unknown Long-Term Effects

NMN has not been studied in humans for 5 or more years. We do not have long-term safety data. For a 30-year-old considering daily NMN for decades, this is an important caveat. NMN is safe in short-term studies, but we lack the decades-long human trials that would fully characterize long-term risk-benefit profiles.

Drug Interactions and Special Populations

NMN's metabolic effects (particularly on AMPK and sirtuins) theoretically could interact with:

• Diabetes medications (metformin, sulfonylureas): NMN's effect on glucose metabolism warrants monitoring
• Immunosuppressants: NMN's immune effects are not fully characterized
• NAD+-consuming medications (nicotinamide itself, some chemotherapy agents)

Individuals on medications should consult their physician before starting NMN.

FDA Status (Resolved)

In September 2025, the U.S. FDA concluded that NMN is not excluded from the definition of a dietary supplement under DSHEA (the Dietary Supplement Health and Education Act), reversing its earlier position. NMN remains classified as a New Dietary Ingredient, so premarket notification requirements and standard structure-function claim rules still apply, and the regulatory picture could continue to evolve. NMN is legal to sell and consume, but our internal evidence and claims rules still govern what we say about it.

Frequently Asked Questions

What is NAD+ exactly, and why should I care?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that powers your cellular energy production and activates sirtuins, which control cellular repair and stress resistance. NAD+ declines significantly with age, contributing to fatigue, metabolic dysfunction, and impaired cellular maintenance. Restoring NAD+ supports the processes that keep your cells working efficiently.

How can I increase NAD+ levels naturally?

The most reliable natural lever is exercise, which stimulates the NAD+ salvage pathway. Caloric restriction, intermittent fasting, dietary polyphenols, quality sleep, and limiting excess alcohol also support NAD+ levels. Precursor supplements like NMN and NR raise NAD+ measurably in human trials, but lifestyle remains the foundation.

Does NMN really increase NAD+ in humans?

Yes. Multiple randomized controlled trials have confirmed that oral NMN at 250 to 600mg per day significantly elevates whole-blood NAD+ levels. The elevation is dose-dependent and measurable. This is established science.

What are the real benefits of NMN? Will it make me feel younger?

The best-supported clinical findings are for sleep quality (in older adults) and insulin sensitivity (in prediabetic populations). Some studies show improved physical performance. However, "feel younger" is subjective and depends on age, health status, and baseline NAD+ levels. NMN's effects depend on where you start. If you're young and healthy, they may be subtle. If you're older or metabolically compromised, they may be more noticeable. Studies are still ongoing.

Is NMN safe long-term?

Short-term safety (4 to 10 weeks) is well-established. Long-term human data (5+ years) does not exist. For a compound you might take for decades, this is an important limitation. Based on available evidence, NMN appears safe, but you should consult your physician before starting, especially if you have metabolic disorders or take medications.

Should I take NMN or NR?

Head-to-head trials put the two on par for raising blood NAD+, with NR ahead in one small, high-dose study. TimeWarp uses NMN because it is one enzymatic step from NAD+ and because the aging-focused functional trials, the walk-speed, sleep, and insulin studies, mostly used NMN.

When should I take NMN, and does timing matter?

Timing may matter for sleep quality. Studies showing sleep benefits used NMN dosed in the evening (after 6 PM). This likely aligns with circadian rhythm optimization. TimeWarp's Energize pill is taken with breakfast and dinner; you could adjust timing to prioritize evening dosing for potential sleep benefits.

Can I get NAD+ from diet?

You cannot get NMN or NR directly from food in significant amounts (some foods contain trace amounts). However, you can support NAD+ metabolism through dietary nicotinamide (in animal proteins), polyphenols (in berries, green tea), and lifestyle factors like exercise and fasting. These are foundational. Supplementation is complementary.

What's the difference between NMN and NAD+ supplements?

NAD+ itself is not a practical oral supplement. It is too large and charged to cross the intestinal wall intact, so enzymes cleave it into nicotinamide and nicotinamide riboside before it reaches circulation. Liposomal encapsulation improves absorption but does not prevent that cleavage. NMN and NR are stable precursors that enter the salvage pathway directly, which is why supplements use precursors rather than NAD+ itself. The full explanation is in the section above.

Key Takeaways

• NAD+ is a fundamental molecule powering energy metabolism and cellular repair. Its decline with age contributes to many signatures of aging.
• Oral NAD+ itself is not a viable delivery route, liposomal or otherwise. It is cleaved before absorption, so precursors are the only established way to raise NAD+ from a capsule.
• NAD+ elevation is established science. NMN and NR supplements significantly raise blood NAD+ at doses of 250 to 600mg daily.
• Clinical benefits are emerging but population-specific. The strongest evidence is for sleep quality (older adults) and insulin sensitivity (metabolically compromised populations). Effects in younger, healthy adults are less clear.
• 350mg NMN is in the clinically studied range and has demonstrated NAD+ elevation. The optimal dose is still being determined.
• NMN vs. NR is not settled. Head-to-head trials show comparable NAD+ elevation. We use NMN for its one-step conversion and the deeper bench of aging-focused human trials.
• Lifestyle interventions come first. Exercise, caloric control, sleep, and stress management naturally support NAD+ metabolism and should be your foundation.
• Short-term safety is good; long-term data is limited. NMN is safe in studies up to 10 weeks. Five-year human safety data doesn't exist yet.
• The evidence is moderate. NAD+ elevation is proven. Clinical benefits show promise but are not proven at the standard of pharmaceutical efficacy. Ongoing research will clarify the picture.
• Supplementation complements lifestyle, it does not replace it. The best approach combines exercise, metabolic health, good sleep, and targeted supplementation to support your cellular energy systems.

What Now?

If you're interested in supporting your NAD+ metabolism and cellular energy production, start with the foundation: consistent exercise (particularly endurance activities), reasonable caloric intake, good sleep, and stress management. These have the strongest evidence base and the broadest health benefits.

If you're 40 or older, metabolically compromised, or want to explore NAD+ supplementation beyond lifestyle, NMN at 250 to 500mg daily is well-studied and appears safe. TimeWarp includes 350mg per day, positioned within the clinically studied range.

If you want to track your progress, biological age testing (via epigenetic clocks like DunedinPACE) can serve as a personal tracking tool to assess the combined impact of lifestyle and supplementation over months and years. No supplement has been proven to reverse biological age in large controlled trials, but individual progress can be encouraging and motivating.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.

About the Author

Dr. Vittorio Sebastiano is Professor of Biological Chemistry at UC Irvine and Adjunct Professor of Obstetrics and Gynecology at Stanford University School of Medicine. He is internationally recognized for pioneering Epigenetic Reprogramming of Aging (ERA), a technology that rejuvenates adult cells while preserving their identity. He has authored more than 50 peer-reviewed publications in Nature, Science, Cell, Nature Biotechnology, and Nature Aging, received the Breakthrough in Gerontology Award and the AFAR Junior Investigator Award, and serves as Associate Editor for Rejuvenation Research.